{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:14:48Z","timestamp":1792610088628,"version":"4.5.0"},"reference-count":53,"publisher":"Walter de Gruyter GmbH","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Plasma homocysteine was assessed in Beh\u00e7et's disease (BD) patients in order to determine the prevalence of hyperhomocysteinaemia in BD and to test its association with clinical manifestations of the disease. The study included 59 patients with BD and 118 age- and sex-matched healthy subjects. Plasma homocysteine, vitamin B<\/jats:p>","DOI":"10.1515\/cclm.2004.263","type":"journal-article","created":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T13:12:46Z","timestamp":1101820366000},"source":"Crossref","is-referenced-by-count":25,"title":["Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Beh\u00e7et's disease"],"prefix":"10.1515","volume":"42","author":[{"given":"Moncef","family":"Feki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Houman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ghannouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Smiti-Khanfir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila El","family":"Matri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderraouf","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neziha","family":"Kaabachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref521","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0161-6420(01)00923-X","article-title":"Homocysteine : a risk factor for retinal venous occlusive disease","volume":"109","author":"Brown","year":"2002","journal-title":"Ophthalmology"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0049-3848(02)00006-3","article-title":"Pathological haemostasis and prothrombotic state in Beh\u00e7et s disease","volume":"105","author":"Kiraz","year":"2002","journal-title":"Thromb Res"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","article-title":"International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease","volume":"103","author":"Bloch","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0002-9343(01)01081-6","article-title":"Beh\u00e7et s syndrome : where do we stand","volume":"112","author":"Yazici","year":"2002","journal-title":"Am J Med"},{"key":"ref481","first-page":"566","article-title":"Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism","volume":"80","author":"Eichinger","year":"1998","journal-title":"Thromb Haemost"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","article-title":"den Hyperhomocysteinemia as a risk factor for deep - vein thrombosis","volume":"334","author":"Heijer","year":"1996","journal-title":"N Engl J Med"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1515\/CCLM.2003.222","article-title":"Interactions of homocysteine nitric oxide folate and radicals in the progressively damaged endothelium","volume":"41","author":"Stanger","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0002-9394(99)00476-6","article-title":"Hyperhomocysteinemia : a risk factor for central retinal vein occlusion","volume":"129","author":"Vin","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1515\/CCLM.2003.215","article-title":"den Hyperhomocysteinaemia as a risk factor for venous thrombosis : an update of the current evidence","volume":"41","author":"Heijer","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"ref161","first-page":"136","article-title":"Meta - analysis of plasma homocysteine serum folate serum vitamin and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease","volume":"12","author":"Cahill","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"ref401","first-page":"197","article-title":"Oxidative stress in Adamantiades - Beh\u00e7et s disease","volume":"8","author":"Freitas","year":"1998","journal-title":"Dermatology"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1163\/15685590260461039","article-title":"Serum homocysteine level in Beh\u00e7et s disease","volume":"32","author":"Calikoglu","year":"2002","journal-title":"Haematologia"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","article-title":"Vascular endothelial function and oxidative stress mechanism in patients with Beh\u00e7et s syndrome","volume":"37","author":"Chambers","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"ref111","first-page":"48","article-title":"Deep vein thrombosis in Beh\u00e7et s disease","volume":"19","author":"Houman","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"ref41","first-page":"341","article-title":"Vascular involvement in Beh\u00e7et s disease : arterial and venous and vessels of all sizes","volume":"19","author":"Lie","year":"1992","journal-title":"J Rheumatol"},{"key":"ref221","first-page":"248","article-title":"Hyperhomocysteinemia and activated protein C resistance in Beh\u00e7et s disease","volume":"9","author":"Altinbas","year":"2000","journal-title":"J Intern Med"},{"key":"ref211","first-page":"1033","article-title":"Beh\u00e7et s disease in Israel : the influence of ethnic origin on disease expression and severity","volume":"28","author":"Krause","year":"2001","journal-title":"J Rheumatol"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0735-1097(02)02069-7","article-title":"Homocysteine impairs coronary microvascular dilator function in humans","volume":"40","author":"Tawakol","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.ATV.0000068684.86135.02","article-title":"ATVB in focus : endothelium : signalling oxidative stress and gene expression","volume":"23","author":"Faraci","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-857X(21)01067-X","article-title":"Vasculitis in Beh\u00e7et s disease","volume":"16","author":"Duffy","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"ref261","article-title":"Serum homocysteine level is higher in Beh\u00e7et s disease with vascular involvement online first","author":"Ates","year":"2003","journal-title":"Rheumatol Int"},{"key":"ref131","first-page":"274","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease Probable benefits of increasing folic acid intakes","volume":"57","author":"Boushey","year":"1995","journal-title":"J Am Med Assoc"},{"key":"ref21","first-page":"150","article-title":"Epidemiology of Adamantiades - Beh\u00e7et s disease","volume":"98","author":"Zouboulis","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref441","first-page":"585","article-title":"Endothelial cell dysfunction in a model of oxidative stress","volume":"7","author":"Jin","year":"2001","journal-title":"Med Sci Monit"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3349\/ymj.2003.44.5.771","article-title":"The serum vitamin C levels in Beh\u00e7et s disease","volume":"44","author":"Noyan","year":"2003","journal-title":"Yonsei Med J"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et s disease","volume":"34","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.ATV.0000061735.85377.40","article-title":"Increased superoxide production in coronary arteries in hyperhomocysteinemia : role of tumor necrosis factor - \u03b1 NAD H oxidase and inducible nitric oxide synthase","volume":"23","author":"Ungvari","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00296-003-0302-7","article-title":"Plasma thrombomodulin levels in patients with Beh\u00e7et s disease","volume":"23","author":"Duzgun","year":"2003","journal-title":"Rheumatol Int"},{"key":"ref321","first-page":"931","article-title":"Plasma homocysteine level and uveitis in Beh\u00e7et s disease","volume":"4","author":"Okka","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/bjo.87.12.1466","article-title":"Fluorescein and indocyanine green angiography findings in Beh\u00e7et s disease","volume":"87","author":"Atmaca","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"ref301","first-page":"329","article-title":"The evaluation of C reactive protein homocysteine and vitamin B concentrations in Beh\u00e7et and rheumatoid arthritis disease","volume":"5","author":"Bekpinar","year":"2003","journal-title":"Clin Chim Acta"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2796.1996.396853000.x","article-title":"Impaired haemostatic kinetics and endothelial function in Beh\u00e7et s disease","volume":"24","author":"Haznedaroglu","year":"1996","journal-title":"J Intern Med"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(02)00085-3","article-title":"Coagulation parameters and plasma total homocysteine levels in Beh\u00e7et s disease","volume":"106","author":"Lee","year":"2002","journal-title":"Thromb Res"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00296-003-0301-8","article-title":"Methylenetetrahydrofolate reductase gene mutation and plasma homocysteine level in Beh\u00e7et s disease","volume":"23","author":"Canataroglu","year":"2003","journal-title":"Rheumatol Int"},{"key":"ref471","first-page":"158","article-title":"Meta - analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease","volume":"6","author":"Ray","year":"1998","journal-title":"Arch Intern Med"},{"key":"ref51","first-page":"246","article-title":"Beh\u00e7et s disease epidemiology and eye manifestations in German and Mediterranean patients","volume":"4","author":"Zierhut","year":"1995","journal-title":"Ger J Ophthalmol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/ard.52.9.659","article-title":"Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases","volume":"52","author":"Bashir","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1191\/1358863x02vm428ra","article-title":"Endothelial function and atherothrombosis in mild hyperhomocysteinemia","volume":"7","author":"Weiss","year":"2002","journal-title":"Vasc Med"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.84.2.154","article-title":"Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease","volume":"84","author":"Cahilla","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjo.82.5.488","article-title":"Treatment of ocular symptoms of Beh\u00e7et s disease with interferon \u03b1 a : a pilot study","volume":"82","author":"K\u00f6tter","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/qjmed\/92.12.727","article-title":"Beh\u00e7et s syndrome : a multidisciplinary approach to clinical care","volume":"92","author":"Whallett","year":"1999","journal-title":"Q J Med"},{"key":"ref271","article-title":"Hyperhomocysteinemia in patients with Beh\u00e7et s disease : is it due to inflammation or therapy online first","author":"Yesilova","year":"2004","journal-title":"Rheumatol Int"},{"key":"ref251","article-title":"Is there an association of plasma homocysteine levels with vascular involvement in patients with Beh\u00e7et s syndrome","volume":"20","author":"Korkmaz","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/rheumatology\/40.6.687","article-title":"Hyperhomocysteinaemia in Beh\u00e7et s disease","volume":"40","author":"Aksu","year":"2001","journal-title":"Rheumatology"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/03009749509095184","article-title":"Plasma von Willebrand factor tissue plasminogen activator plasminogen activator inhibitor and antithrombin III levels in Beh\u00e7et s disease","volume":"24","author":"Ozoran","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"ref541","first-page":"249","article-title":"[ Retinal vein occlusion and hyperhomocysteinemia ]","volume":"26","author":"Blondel","year":"2003","journal-title":"J Fr Ophtalmol"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/112067210201200608","article-title":"Attas OS Hyperhomocysteinemia and retinal vascular occlusive disease","volume":"12","author":"Abu","year":"2002","journal-title":"Eur J Ophthalmol"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bjo.86.6.653","article-title":"Serum homocysteine level is increased and correlated with endothelin - and nitric oxide in Beh\u00e7et s disease","volume":"86","author":"Er","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/eye.2000.148","article-title":"Plasma total homocysteine and retinal vascular disease","volume":"14","author":"Martin","year":"2000","journal-title":"Eye"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bjo.83.11.1287","article-title":"Hyperhomocysteinaemia in young patients with non - arteritic anterior ischaemic optic neuropathy","volume":"83","author":"Kawasaki","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08830189709116845","article-title":"Uveitis in Beh\u00e7et s disease","volume":"14","author":"Nussenblatt","year":"1997","journal-title":"Int Rev Immunol"},{"key":"ref331","first-page":"1691","article-title":"Effects of factor V gene methylenetetrahydrofolate reductase gene and prothrombin gene mutations on deep venous thrombogenesis in Beh\u00e7et s disease","volume":"27","author":"Toydemir","year":"2000","journal-title":"J Rheumatol"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","article-title":"Beh\u00e7et s disease","volume":"27","author":"Kaklamani","year":"1998","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2004.42.issue-12\/cclm.2004.263\/cclm.2004.263.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2004.263\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T02:53:01Z","timestamp":1625021581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2004.263\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":53,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1515\/cclm.2004.263","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}